skip to main content

Amiodarone safety monitoring — GPhC CRA MCQ

Instant feedback + full explanation. One question, done properly.

ModerateCardiovascular TherapeuticsAmiodarone safety monitoringGPhC CRA

A 73-year-old man taking amiodarone long term asks why his GP requests regular blood tests and a chest review. He has developed mild breathlessness on exertion. What monitoring is required?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: A — Thyroid, liver and pulmonary toxicity monitoring is required

Amiodarone can cause thyroid dysfunction, hepatotoxicity and pulmonary toxicity, among other adverse effects. New breathlessness should be assessed promptly because pulmonary toxicity can be serious. Monitoring goes beyond simple dose titration.

Reference: BNF